Natural killer cells determine the outcome of B cell–mediated autoimmunity (original) (raw)

• Tak, P. P. et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum. 37, 1735–1743 (1994).
  Article CAS Google Scholar
• Dalakas, M. C. & Illa., I. Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells. Ann. Neurol. 37, 806–810 (1995).
  Article CAS Google Scholar
• Garcia-Suarez, J. et al. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br. J. Haemat. 89, 653–655 (1995).
  Article CAS Google Scholar
• Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. & Tabira, T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186,1677–1687 (1997).
  Article CAS Google Scholar
• Matsumoto, Y. et al. Role of natural killer cells and TCRγδ T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28, 1681–1688 (1998).
  Article CAS Google Scholar
• Fort, M. M., Leach, M. W. & Rennick, D. M. A role for NK cells as regulator of CD4+ T cells in a transfer model of colitis. J. Immunol. 161, 3256–3261 (1998).
  CAS PubMed Google Scholar
• Lehuen, A. et al. Overexpression of natural killer T cells protects Vα 14-Jα 281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831–1839 (1998).
  Article CAS Google Scholar
• Litzenburger, T. et al. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188, 169–180 (1998).
  Article CAS Google Scholar
• Drachman, D. B. Myasthenia gravis. N. Engl. J. Med. 330, 1797–1810 (1994).
  Article CAS Google Scholar
• Berman, P. W. & Patrick, J. Experimental myasthenia gravis: a murine system. J. Exp. Med. 151, 204–223 (1980).
  Article CAS Google Scholar
• Balasa, B. et al. Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental myasthenia gravis in mice. J. Exp. Med. 186, 385–391 (1997).
  Article CAS Google Scholar
• Moiola, L. et al. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody mediated disease. Eur. J. Immunol. 28, 2487–2497 (1998).
  Article CAS Google Scholar
• Shi, F. -D. et al. Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis. Eur. J. Immunol. 28, 3587–3593 (1998).
  Article CAS Google Scholar
• Cui, J.Q. et al. Requirement for Vα 14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623–1626 (1997).
  Article CAS Google Scholar
• Mendiratta, S.K. et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6, 469–477 (1997).
  Article CAS Google Scholar
• Mason, D. & Powrie, F. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10, 649–655 (1998).
  Article CAS Google Scholar
• Chen, W., Jin, W. & Wahl, S. M. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells. J. Exp. Med. 188, 1849–1857 (1998).
  Article CAS Google Scholar
• Okamura, H. et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88–91 (1995).
  Article CAS Google Scholar
• Takeda, K. et al. Defective NK cell activity and Th1 responses in IL-18-deficient mice. Immunity 8, 383–390 (1998).
  Article CAS Google Scholar
• Romagnani, S. Induction of TH1 and TH2 responses: a key role for the “natural” immune responses? Immunol. Today. 13, 379–311 (1992).
  Article CAS Google Scholar
• Douglas, T. F. The instructive role of innate immunity in the acquired immune response. Science 272, 50–54 (1996).
  Article Google Scholar
• Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992).
  Article CAS Google Scholar
• Dalton, D.K. et al. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739–1745 (1993).
  Article CAS Google Scholar
• Shi, F. -D. et al. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells. J. Immunol. 162, 5757–5763 (1999).
  CAS PubMed Google Scholar
• Gray, J. D., Hirokawa. M. & Horwitz. D. A. The role of TGF-β in the generation of suppression: an interaction between CD8+ T and NK cells. J. Exp. Med. 180, 1937–1942 (1994).
  Article CAS Google Scholar
• Gray, J. D., Hirokawa, M., Ohtsuka, K. & Horwitz, D. A. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-β: Contrasting effects of anti-CD2 and anti-CD3. J. Immunol. 160, 2248–2254 (1998).
  CAS PubMed Google Scholar
• Yuan, D., Koh, C. Y. & Wilder, J. A. Interactions between B lymphocytes and NK cells. FASEB J. 8, 1012–1018 (1994).
  Article CAS Google Scholar
• Seaman, W. E., Sleisenger, M., Eriksson, E. & Koo., G. C. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1: Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138, 4539–4544 (1987).
  CAS PubMed Google Scholar
• Snapper, C. M. & Mond, J. J. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14, 15–18 (1993).
  Article CAS Google Scholar
• Ridderstad, A., Lettesjö, H., Abedi-Valugerdi, M. & Möller, E. Differential sensitivity to transforming growth factor (TGF)-β of CBA and of CBA/N B cells demonstrates that the IgG2b inducing factor in synovial fluid from rheumatoid arthritis patients is not identical to TGF-β. Int. Immunol. 7, 459–469 (1995).
  Article CAS Google Scholar
• Hong, S. et al. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol. Rev. 169, 31–44 (1999).
  Article CAS Google Scholar
• Rauch, H. C., Montgometry, I. N. & Kaplan, J. Natural killer cell activity in multiple sclerosis and myasthenia gravis. Immunol. Invest. 14, 427–434 (1985).
  Article CAS Google Scholar
• Vranes, Z., Poljakovic, Z. & Marusic, M. Natural killer cell number and activity in multiple sclerosis. J. Neurol. Sci. 94, 115–123 (1989).
  Article CAS Google Scholar
• Lindstrom J., Einarson, B. & Tzartos, S. Production and assay of antibodies to AChR. Methods Enzymol. 74, 432–460 (1981).
  Article CAS Google Scholar
• Deibler, G. E., Martensson, R. E. & Kies, M. W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2, 139–164 (1972).
  CAS PubMed Google Scholar
• Koo, G. C. & Peppard, J. R. Establishment of monoclonal anti-NK1.1 antibody. Hybridoma 3, 301–303 (1984).
  Article CAS Google Scholar
• Dasch, J. R., Pace, D. R., Waegell, W., Ineaga, D. & Ellingsworth, L. Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor-β2 affinity purification. J. Immunol. 142, 1536–1541 (1989).
  CAS PubMed Google Scholar
• Chambers, B. J., Salcedo, M. & Ljunggren, H. G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5, 311–317 (1996).
  Article CAS Google Scholar
• Korsgren, M. et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 189, 553–562 (1999).
  Article CAS Google Scholar